|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-2-9
|
|
pubmed:abstractText |
Chemotherapy sensitivity, defined simply as at least a partial response to chemotherapy, is an important outcome predictor for non-Hodgkin lymphoma (NHL) patients undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (allo-HCT). The authors hypothesized that further differentiation of chemotherapy sensitivity by specific response, complete remission (CR) versus partial remission (PR) versus stable disease (SD) versus progression of disease (PD), correlates with post-transplant outcomes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
116
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
852-62
|
|
pubmed:meshHeading |
pubmed-meshheading:20041482-Adult,
pubmed-meshheading:20041482-Aged,
pubmed-meshheading:20041482-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20041482-Clinical Trials as Topic,
pubmed-meshheading:20041482-Cyclophosphamide,
pubmed-meshheading:20041482-Disease-Free Survival,
pubmed-meshheading:20041482-Doxorubicin,
pubmed-meshheading:20041482-Etoposide,
pubmed-meshheading:20041482-Female,
pubmed-meshheading:20041482-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:20041482-Humans,
pubmed-meshheading:20041482-Lymphoma, Non-Hodgkin,
pubmed-meshheading:20041482-Male,
pubmed-meshheading:20041482-Middle Aged,
pubmed-meshheading:20041482-Postoperative Period,
pubmed-meshheading:20041482-Prednisone,
pubmed-meshheading:20041482-Preoperative Period,
pubmed-meshheading:20041482-Survival Rate,
pubmed-meshheading:20041482-Transplantation, Autologous,
pubmed-meshheading:20041482-Transplantation Conditioning,
pubmed-meshheading:20041482-Treatment Outcome,
pubmed-meshheading:20041482-Vincristine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Correlation of pretransplant and early post-transplant response assessment with outcomes after reduced-intensity allogeneic hematopoietic stem cell transplantation for non-Hodgkin's lymphoma.
|
|
pubmed:affiliation |
Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, 10 Center Drive, CRC/Room 4-3152, Bethesda, MD 20892, USA. mbishop@mail.nih.gov
|
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Intramural
|
